Revista de la Sociedad Argentina de Diabetes (Sep 2022)
Symposium 3: HbA1c: Are HbA1c determinations reliable enough today in Argentina to adopt them as diagnostic criteria?
Abstract
The standardization and efforts in the harmonization of the analytical process of Glycated Hemoglobin (HbA1c), its low biological variability, the possibility of performing the test without fasting, among others1, led the American Diabetes Association (ADA) to recommend HbA1c for the detection and diagnosis of diabetes in 2010. Similar recommendations were endorsed by the IDF and WHO2. Currently few methods show interference by one or more of the most common heterozygous hemoglobin variants. Others, such as ion exchange HPLC and capillary electrophoresis, detect them and alert about their presence. Rare hemoglobin variants may interfere with tests for HbA1c, which is specific to the method used.
Keywords